Articles by J. E. Crowe | Synthical

Synthical

Your space

Profile

Activity

Favorites

Folders

Feeds

Contacts

About

Claim page

J. E. Crowe

Follow

Activity

Upvotes

Folders

Articles

25

Structural Mapping of Polyclonal IgG Responses to HA After Influenza Virus Vaccination or Infection

6 February 2025 by A. Leon and others

Protective threshold of a potent neutralizing Zika virus monoclonal antibody in rhesus macaques

15 November 2024 by J. Nkolola and others at

Beth Israel Deaconess Medical Center

Potently neutralizing human monoclonal antibodies against the zoonotic pararubulavirus Sosuga virus

28 February 2023 by H. Parrington and others at

Vanderbilt University Medical Center

Neutralization Fingerprinting Technology for Characterizing Polyclonal Antibody Responses to Dengue Vaccines

13 December 2022 by Natarajan Raju and others

Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains

2 July 2022 by James Brett Case and others at

Washington University School of Medicine

Single-Cell Profiling of the Antigen-Specific Response to BNT162b2 SARS-CoV-2 RNA Vaccine

16 June 2022 by K. Kramer and others at

Vanderbilt University Medical Center

Structural mapping of antibody landscapes to human betacoronavirus spike proteins

4 May 2022 by S. Bangaru and others at

The Scripps Research Institute

An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer

26 April 2022 by Nithin Suryadevara and others at

Vanderbilt University Medical Center

Isolation of a potently neutralizing and protective human monoclonal antibody targeting yellow fever virus

14 April 2022 by J. Crowe and others at

Vanderbilt University Medical Center

AZD7442 demonstrates prophylactic and therapeutic efficacy in non-human primates and extended half-life in humans

25 January 2022 by Y. -M. Loo and others

Infectious Diseases

An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by several therapeutic monoclonal antibodies

19 January 2022 by L. Vanblargan and others at

Washington University

Potent neutralization of SARS-CoV-2 variants of concern by an antibody with a unique genetic signature and structural mode of spike recognition

16 September 2021 by K. Kramer and others at

Vanderbilt University Medical Center

Functional cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein

31 August 2021 by M. Doyle and others at

Vanderbilt University Medical Center

A potently neutralizing anti-SARS-CoV-2 antibody inhibits variants of concern by binding a highly conserved epitope

19 August 2021 by L. Vanblargan and others at

Washington University School of Medicine

Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals

10 August 2021 by E. Chen and others at

Vanderbilt University Medical Center

Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface

22 June 2021 by S. Zost and others at

Vanderbilt University Medical Center

Convergence of a common solution to broad ebolavirus neutralization by glycan cap directed human antibodies

15 April 2021 by C. Murin and others at

The Scripps Research Institute

Neutralizing and protective human monoclonal antibodies recognizing the N-terminaldomain of the SARS-CoV-2 spike protein

18 March 2021 by Nithin Suryadevara and others at

Vanderbilt University Medical Center

Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protection

15 February 2021 by E. Winkler and others at

Washington University

Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition

20 November 2020 by A. Greaney and others

Integrated technology platform for accelerated discovery of antiviral antibody therapeutics

3 August 2020 by P. Gilchuk and others at

Vanderbilt University Medical Center

Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals

15 July 2020 by S. Zost and others at

Vanderbilt University Medical Center

Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein

10 July 2020 by S. Zost and others at

Vanderbilt University Medical Center

Multi-State Design of Flexible Proteins Predicts Sequences Optimal for Conformational Change

7 February 2020 by M. Sauer and others at

Vanderbilt University

Broad Dengue Neutralization in Mosquitoes Expressing an Engineered Antibody

16 January 2020 by A. Buchman and others at

Peptide Arrays of Three Collections of Human Sera from Patients Infected with Mosquito-Borne Viruses

7 November 2019 by M. D. P. Martinez Viedma and others

Potent anti-influenza H7 human monoclonal antibody induces separation of hemagglutinin receptor binding head domains

4 February 2019 by H. Turner and others at

The Scripps Research Institute

This is an AI-generated summary

Key points

Topics

Immunology Microbiology Infectious Diseases Biophysics Bioengineering